SCHEMBL2587065

SCHEMBL2587065

CC(C)(C)OC(=O)N1CCc2onc(C(=O)NCC3CC3)c2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
PKM P14618 1/20 0.47
HSP90AA1 P07900 8/20 0.45
LMNA P02545 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
NAMPT P43490 2/20 0.39
PIK3CD O00329 1/20 0.39
HPGD P15428 1/20 0.38
TP53 P04637 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22615316 0.84 SMN1; SMN2 (0.55) KDM4EHSP90AA1LMNAMEN1KMT2A
SCHEMBL22621730 0.84 HSP90AA1 (0.43) KDM4EHSP90AA1LMNASMN1; SMN2ALDH1A1
SCHEMBL22481978 0.83 HSP90AA1 (0.45) HSP90AA1LMNAMEN1KMT2ATSHR
SCHEMBL22481977 0.80 USP2 (0.42) KDM4EHSP90AA1MEN1KMT2ASMN1; SMN2
SCHEMBL2576275 0.80 ADORA1 (0.46) HSP90AA1MEN1KMT2AMAPK1SMN1; SMN2
SCHEMBL5465401 0.80 KDM4E (0.47) KDM4EPKMSMN1; SMN2NAMPTPIK3CD
SCHEMBL29425100 0.78 HSP90AA1 (0.41) HSP90AA1LMNAMEN1KMT2ATSHR
SCHEMBL2582147 0.78 HSP90AA1 (0.58) HSP90AA1LMNAMEN1KMT2ANPSR1
SCHEMBL2587066 0.77 USP2 (0.41) HSP90AA1ALDH1A1USP2POLB
SCHEMBL3441391 0.76 KMT2A (0.57) HSP90AA1LMNAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869053-B1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-ISOXAZOLO[4,5-C]PYRIDINE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS GRUENENTHAL GMBH (DE) 2013-10-09 EP disclosed
US-8048879-B2 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-11-01 US disclosed
US-8048879-B2 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-11-01 US disclosed
US-8048879-B2 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-11-01 US disclosed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments P2RX5, P2RX4, P2RX7 KDM4E 1123/4885PKM 1032/4885HSP90AA1 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.